Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide [J]
47 This creates a perverse incentive
Using hormonal contraception to stop your periods doesn't affect your long-term fertility
Researchers value retatrutide for exploring how simultaneous modulation of these incretin and glucagon pathways can achieve superior outcomes compared to existing dual-agonist profiles, potentially redefining therapeutic strategies for obesity, type 2 diabetes, and related cardiometabolic disorders
Of patients taking GLP-1, 8.9% developed NAION compared to 1.8% of patients taking other medications
While side effects are generally minor and infrequent, these may include allergic reactions, diarrhea, vomiting, and nausea